Results 141 to 150 of about 76,618 (225)

Anti-Inflammatory and Synaptic Protective Effects of TNF-α Inactivation in the MDX Mouse Model. [PDF]

Curr Issues Mol Biol
Bonani AO, Matheus V, Tomiyama ALMR, de Oliveira ALR.   +3 more
europepmc   +1 more source

Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan. [PDF]

J Pharm Policy Pract
Mamiya H, Fukasawa T, Kawakami K.
europepmc   +1 more source

RETRACTED: Cordaro et al. Role of Etanercept and Infliximab on Nociceptive Changes Induced by the Experimental Model of Fibromyalgia. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6139. [PDF]

Int J Mol Sci
Cordaro M, Siracusa R, D'Amico R, Genovese T, Franco G, Marino Y, Paola DD, Cuzzocrea S, Impellizzeri D, Paola RD, Fusco R.   +10 more
europepmc   +1 more source

Biosimilars in Adult and Pediatric Noninfectious Uveitis. [PDF]

Clin Ophthalmol
Ploeger CG, Carvalho Soares Valentim C, Guner ME, Kabaalioglu Guner M.   +3 more
europepmc   +1 more source

NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials [PDF]

, 2011
Ades, AE, Dias, S, Sutton, AJ, Welton, NJ   +3 more
core   +2 more sources

Mincle-dependent Th17 adjuvanticity requires TNFR1 signaling in myeloid cells. [PDF]

Front Immunol
Blamberg R, Haberkamp C, Pedersen GK, Rosenkrands I, Schleicher U, Schraml BU, Yamasaki S, Lang R.   +7 more
europepmc   +1 more source

The effect of the nonselective TNF inhibitor etanercept and of the selective TNF inhibitor XPro1595 on lesioned supraspinatus muscle. [PDF]

Biosci Rep
Aboo C, Lambertsen KL, Nasseri S, Ding M, Jensen PT, Linh Ta TM, Ditzel N, Schrøder HD, Stensballe A, Hejbøl EK, Frich LH.   +10 more
europepmc   +1 more source

Selective Inhibition of Tumor Necrosis Factor for Attenuating Alzheimer's Disease: Strategies Targeting Neuroinflammation. [PDF]

Inflammation
Udaiyappan JP, Balakrishnan R, Tamilarasan MM, Balasubramanian B, Abass KS.   +4 more
europepmc   +1 more source

Circulating Aggrecan, Biglycan, and Decorin as Biomarkers of Osteoarticular Alterations in Juvenile Idiopathic Arthritis-A Preliminary Study. [PDF]

Int J Mol Sci
Kuźnik-Trocha K, Winsz-Szczotka K, Olczyk K, Gruenpeter A, Komosińska-Vassev K.   +4 more
europepmc   +1 more source

Optimizing human FcRn mouse models to improve pharmacokinetic evaluation of antibody drug candidates. [PDF]

MAbs
Christianson G, Howard ZM, Kenney S, Lowell E, Bethur N, Roopenian D, Gonzalo-Gil E.   +6 more
europepmc   +1 more source